Merck KGaA Hopes UK Cancer Charity R&D Pact Will Yield New Assets

 
• By Sten Stovall

The multi-project collaboration and licensing deal between charities Cancer Research UK and Germany's Merck aims to discover and commercialize novel cancer treatment assets.

R&D
Merck has Global Rights to molecules discovered by Its New UK R&D Pact • Source: Shutterstock

More from Deals

More from Business